Haplo is the new black.

Published in: Blood (2014)

In this edition of Blood, Bertaina et al report 3-year survival exceeding 90% by using haploidentical αβ+CD3+/CD19+-depleted allogeneic transplantation for children with nonmalignant disorders.

Keyphrases

stem cell transplantation
bone marrow
high dose
young adults
peripheral blood
cell therapy
free survival
stem cells
low dose
hematopoietic stem cell